382 related articles for article (PubMed ID: 36615886)
1. Ceramides in Autoimmune Rheumatic Diseases: Existing Evidence and Therapeutic Considerations for Diet as an Anticeramide Treatment.
Alexandropoulou I; Grammatikopoulou MG; Gkouskou KK; Pritsa AA; Vassilakou T; Rigopoulou E; Lindqvist HM; Bogdanos DP
Nutrients; 2023 Jan; 15(1):. PubMed ID: 36615886
[TBL] [Abstract][Full Text] [Related]
2. Extracting immunological and clinical heterogeneity across autoimmune rheumatic diseases by cohort-wide immunophenotyping.
Tanaka H; Okada Y; Nakayamada S; Miyazaki Y; Sonehara K; Namba S; Honda S; Shirai Y; Yamamoto K; Kubo S; Ikari K; Harigai M; Sonomoto K; Tanaka Y
Ann Rheum Dis; 2024 Jan; 83(2):242-252. PubMed ID: 37903543
[TBL] [Abstract][Full Text] [Related]
3. The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer.
Hait NC; Maiti A
Mediators Inflamm; 2017; 2017():4806541. PubMed ID: 29269995
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine kinase signalling in immune cells: potential as novel therapeutic targets.
Melendez AJ
Biochim Biophys Acta; 2008 Jan; 1784(1):66-75. PubMed ID: 17913601
[TBL] [Abstract][Full Text] [Related]
5. Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients.
Myśliwiec H; Baran A; Harasim-Symbor E; Choromańska B; Myśliwiec P; Milewska AJ; Chabowski A; Flisiak I
Arch Dermatol Res; 2017 Mar; 309(2):79-86. PubMed ID: 27988894
[TBL] [Abstract][Full Text] [Related]
6. Lipid metabolism in autoimmune rheumatic disease: implications for modern and conventional therapies.
Robinson G; Pineda-Torra I; Ciurtin C; Jury EC
J Clin Invest; 2022 Jan; 132(2):. PubMed ID: 35040437
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory rheumatic diseases developed after COVID-19 vaccination: presentation of a case series and review of the literature.
Akkuzu G; Bes C; Özgür DS; Karaalioğlu B; Mutlu MY; Yıldırım F; Atagündüz P; Gündüz A; Soy M
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2143-2151. PubMed ID: 36930514
[TBL] [Abstract][Full Text] [Related]
8. Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases.
Manolis AS; Tzioufas AG
Curr Vasc Pharmacol; 2020; 18(6):533-537. PubMed ID: 32693768
[TBL] [Abstract][Full Text] [Related]
9. Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate.
Gomez-Muñoz A; Presa N; Gomez-Larrauri A; Rivera IG; Trueba M; Ordoñez M
Prog Lipid Res; 2016 Jan; 61():51-62. PubMed ID: 26703189
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine-1-phosphate and ceramide-1-phosphate promote migration, pro-inflammatory and pro-fibrotic responses in retinal pigment epithelium cells.
Simón MV; Vera MS; Tenconi PE; Soto T; Prado Spalm FH; Torlaschi C; Mateos MV; Rotstein NP
Exp Eye Res; 2022 Nov; 224():109222. PubMed ID: 36041511
[TBL] [Abstract][Full Text] [Related]
11. Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target?
Manolis AS; Tzioufas AG
Curr Vasc Pharmacol; 2020; 18(5):425-430. PubMed ID: 32410564
[TBL] [Abstract][Full Text] [Related]
12. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
13. A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury.
Ueda N
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409370
[TBL] [Abstract][Full Text] [Related]
14. Practical use of immunosuppressive drugs in autoimmune rheumatic diseases.
De Jesus A; Talal N
Crit Care Med; 1990 Feb; 18(2 Suppl):S132-7. PubMed ID: 2298028
[TBL] [Abstract][Full Text] [Related]
15. Current perspective on rituximab in rheumatic diseases.
Schioppo T; Ingegnoli F
Drug Des Devel Ther; 2017; 11():2891-2904. PubMed ID: 29042750
[TBL] [Abstract][Full Text] [Related]
16. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders.
Czubowicz K; Jęśko H; Wencel P; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2019 Aug; 56(8):5436-5455. PubMed ID: 30612333
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling.
Chalfant CE; Spiegel S
J Cell Sci; 2005 Oct; 118(Pt 20):4605-12. PubMed ID: 16219683
[TBL] [Abstract][Full Text] [Related]
18. Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases.
Rafael-Vidal C; Pérez N; Altabás I; Garcia S; Pego-Reigosa JM
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993066
[TBL] [Abstract][Full Text] [Related]
19. Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019.
Winthrop KL; Weinblatt ME; Bathon J; Burmester GR; Mease PJ; Crofford L; Bykerk V; Dougados M; Rosenbaum JT; Mariette X; Sieper J; Melchers F; Cronstein BN; Breedveld FC; Kalden J; Smolen JS; Furst D
Ann Rheum Dis; 2020 Jan; 79(1):88-93. PubMed ID: 31662322
[TBL] [Abstract][Full Text] [Related]
20. Role of bioactive sphingolipids in physiology and pathology.
Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A
Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
